(2R,4S,5S,7S)-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-amino-N-(3-amino-3-oxopropyl)-4-hydroxy-2,8-dimethylnonanamide hydrochloride

ID: ALA537666

Chembl Id: CHEMBL537666

PubChem CID: 23626421

Max Phase: Preclinical

Molecular Formula: C26H46ClN3O6

Molecular Weight: 495.66

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C)C(=O)NCCC(N)=O)C(C)C)ccc1OC.Cl

Standard InChI:  InChI=1S/C26H45N3O6.ClH/c1-17(2)20(14-19-7-8-23(34-5)24(15-19)35-12-6-11-33-4)16-21(27)22(30)13-18(3)26(32)29-10-9-25(28)31;/h7-8,15,17-18,20-22,30H,6,9-14,16,27H2,1-5H3,(H2,28,31)(H,29,32);1H/t18-,20+,21+,22+;/m1./s1

Standard InChI Key:  XDDTZGCWCZBADK-RKBSWOHJSA-N

Associated Targets(Human)

REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

REN Renin (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSD Cathepsin D (510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.66Molecular Weight (Monoisotopic): 495.3308AlogP: 2.02#Rotatable Bonds: 18
Polar Surface Area: 146.13Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 1.29CX LogD: -0.83
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.23Np Likeness Score: 0.16

References

1. Göschke R, Stutz S, Rasetti V, Cohen NC, Rahuel J, Rigollier P, Baum HP, Forgiarini P, Schnell CR, Wagner T, Gruetter MG, Fuhrer W, Schilling W, Cumin F, Wood JM, Maibaum J..  (2007)  Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.,  50  (20): [PMID:17824679] [10.1021/jm070314y]
2. Maibaum J, Stutz S, Göschke R, Rigollier P, Yamaguchi Y, Cumin F, Rahuel J, Baum HP, Cohen NC, Schnell CR, Fuhrer W, Gruetter MG, Schilling W, Wood JM..  (2007)  Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.,  50  (20): [PMID:17824680] [10.1021/jm070316i]

Source